Combination therapy with infliximab and immunomodulators: is the glass half empty?

MeSH terms

• Anti-Inflammatory Agents / administration & dosage*
• Anti-Inflammatory Agents / adverse effects
• Anti-Inflammatory Agents / pharmacokinetics
• Antibodies, Monoclonal / administration & dosage*
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / pharmacokinetics
• C-Reactive Protein / metabolism
• Crohn Disease / drug therapy*
• Crohn Disease / metabolism
• Crohn Disease / pathology
• Drug Administration Schedule
• Drug Therapy, Combination
• Gastrointestinal Agents / administration & dosage*
• Gastrointestinal Agents / adverse effects
• Gastrointestinal Agents / pharmacokinetics
• Humans
• Immunosuppressive Agents / administration & dosage*
• Infliximab
• Intestinal Mucosa / drug effects
• Intestinal Mucosa / pathology
• Patient Selection
• Research Design
• Treatment Outcome